Close
ACHEMA MIDDLE EAST 2026

GTP Bioways invests €12M in two GMP biopharmaceutical production units

GTP Bioways, a CDMO (Contract Development and Manufacturing Organization) specializing in the production of biotherapies and nanotherapies, announces an investment of €12M ($14M) into...

UCB to license its AI technology that improves identification of Osteoporosis to ImageBiopsy Lab

UCB announced a strategic out-licensing of Artificial Intelligence (AI) based fracture identification technology, BoneBot, to ImageBiopsy Lab to bring the new identification tool to...

Moderna Announces MOU to Supply up to 110 Million Doses of Its COVID-19 Vaccine to the African Union

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a new Memorandum of Understanding (MoU) to make up to 110...

Moderna Announces EMA’s Committee for Medicinal Products for Human Use Recommends Booster Dose of Moderna’s COVID-19 Vaccine in the European Union

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for...

Ubiquigent Extends and Expands Drug Discovery Collaboration With Bristol Myers Squibb

Ubiquigent Limited announces the extension and expansion of its long-term collaboration with Bristol Myers Squibb. Under the terms of the agreement, Ubiquigent will provide...

Aptar Pharma and i2c Pharmaceutical Services Announce Partnership for Next Generation Propellant Dispersible Tablet pMDI Technology

Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, and i2c Pharmaceutical Services, a leading service provider for...

Vetter’s Contribution to Climate Protection: Corporate Sites Around the World are CO2-Neutral

The “Green Deal” initiated by the European Commission aims at reducing the net emissions of greenhouse gases to zero across the EU by 2050,...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...